(Q36888392)

16 August 2017

1 reference

title

New therapeutic options in uveitis (English)

1 reference

16 August 2017

1 reference

Lightman S

1

1 reference

16 August 2017

publication date

1 January 1997

1 reference

16 August 2017

1 reference

16 August 2017

volume

11 ( Pt 2)

1 reference

16 August 2017

page(s)

222-226

1 reference

https://scigraph.springernature.com/pub.10.1038/eye.1997.56

16 August 2017

exact match

0 references

cites work

Causes and frequency of blindness in patients with intraocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Immune mechanisms in choroido-retinal inflammation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Antiproliferative effects of methotrexate on peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Low-dose methotrexate therapy for ocular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Combined cyclosporin A-steroid-MTX treatment in endogenous non-infectious uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Replacing ganciclovir implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Exudative macular degeneration and intravitreal triamcinolone. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Suramin treatment suppresses induction of experimental autoimmune uveoretinitis (EAU) in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Therapeutic pars plana vitrectomy for chronic uveitis: a retrospective study of the long-term results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Macular grid laser photocoagulation in uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

Orbital floor steroid injections in the treatment of uveitis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

Response of immunoregulatory lymphocyte subsets to methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

Methotrexate in the treatment of arthritis and connective tissue diseases

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

Anti-CD4 therapy in recent-onset IDDM.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

A clinical trial of FK506 in refractory uveitis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

FK506 treatment of noninfectious uveitis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

Intravitreal corticosteroids as an adjunct in the treatment of bacterial and fungal endophthalmitis. A review

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

Leflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

[Early vitrectomy in endogenous juvenile uveitis intermedia--a long-term study]

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.56

7 January 2021

Identifiers

DOI

10.1038/EYE.1997.56

1 reference

16 August 2017

1 reference